A quantitative study of epidermal Langerhans cells in cutaneous leishmaniasis caused by Leishmania tropica

Objective  The purpose of this study was to characterize the number and distribution of epidermal Langerhans cells in different clinical forms of dry‐type cutaneous leishmaniasis (CL). Methods  Sixteen cases of dry‐type cutaneous leishmaniasis caused by Leishmania tropica were studied. These cases w...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of dermatology 2004-11, Vol.43 (11), p.819-823
Hauptverfasser: Meymandi, Simin, Dabiri, Shahriar, Dabiri, Darya, Crawford, Richard I., Kharazmi, Arsalan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Objective  The purpose of this study was to characterize the number and distribution of epidermal Langerhans cells in different clinical forms of dry‐type cutaneous leishmaniasis (CL). Methods  Sixteen cases of dry‐type cutaneous leishmaniasis caused by Leishmania tropica were studied. These cases were classified clinically as five cases of acute leishmaniasis with indurated papules, nodules and plaques with central crust formation and duration  2 years, and five cases of chronic nonlupoid type with nonhealing lesions of duration > 2 years. Paraffin‐embedded blocks were stained with hematoxylin and eosin (H&E) and stained immunohistochemically for CD1a. Results  The number of Langerhans cells per millimeter length of epidermis was increased in acute cases compared to chronic and lupoid cases. Conclusions  Lesions of acute leishmaniasis contain the greatest amounts of antigen for presentation, so Langerhans cells increase in number and in trafficking to present antigens derived from Leishman bodies to the cellular immune system. In chronic leishmaniasis, the Langerhans cell population is reduced, perhaps because of exhaustion of the source of Langerhans cells, or because of reduced response to modified antigen.
ISSN:0011-9059
1365-4632
DOI:10.1111/j.1365-4632.2004.02359.x